Literature DB >> 21530743

Regulation of homeostasis and inflammation in the intestine.

Thomas T MacDonald1, Ivan Monteleone, Massimo Claudio Fantini, Giovanni Monteleone.   

Abstract

The gastrointestinal tract is the largest immune interface with the environment. Exposure to large numbers of dietary and microbial antigens requires complex and highly regulated immune responses by different mucosal cell types, which result in the induction and maintenance of intestinal homeostasis. Defects in this equilibrium can disrupt the homeostatic mechanisms and lead to chronic intestinal inflammation. We review the cell populations and mechanisms involved in the control of intestinal homeostasis and inflammation, focusing on inflammatory bowel diseases. We describe some aspects of gut immunity that could alter the delicate balance between inflammatory and tolerogenic responses and result in chronic gastrointestinal tract inflammation in patients.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530743     DOI: 10.1053/j.gastro.2011.02.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  98 in total

1.  Cytokine production and antigen recognition by human mucosal homing conjunctival effector memory CD8+ T cells.

Authors:  Geraint P Williams; Annette Pachnio; Heather M Long; Saaeha Rauz; S John Curnow
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-13       Impact factor: 4.799

2.  CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice.

Authors:  Oscar Medina-Contreras; Duke Geem; Oskar Laur; Ifor R Williams; Sergio A Lira; Asma Nusrat; Charles A Parkos; Timothy L Denning
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

3.  New cytokine targets in inflammatory bowel disease.

Authors:  Thomas T Macdonald
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-07

4.  Isolation and characterization of dendritic cells and macrophages from the mouse intestine.

Authors:  Duke Geem; Oscar Medina-Contreras; Wooki Kim; Clifton S Huang; Timothy L Denning
Journal:  J Vis Exp       Date:  2012-05-21       Impact factor: 1.355

Review 5.  Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease.

Authors:  Antonio Di Sabatino; Lucio Liberato; Monia Marchetti; Paolo Biancheri; Gino R Corazza
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

6.  Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.

Authors:  Ning Lu; Lihong Wang; Hailong Cao; Liping Liu; Luc Van Kaer; Mary K Washington; Michael J Rosen; Philip E Dubé; Keith T Wilson; Xiubao Ren; Xishan Hao; D Brent Polk; Fang Yan
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

7.  Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.

Authors:  Cynthia E Cherfane; Luke Gessel; Dominic Cirillo; Miriam B Zimmerman; Steven Polyak
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

Review 8.  Antisense approach to inflammatory bowel disease: prospects and challenges.

Authors:  Irene Marafini; Davide Di Fusco; Emma Calabrese; Silvia Sedda; Francesco Pallone; Giovanni Monteleone
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

Review 9.  Therapy with stem cells in inflammatory bowel disease.

Authors:  María Del Pilar Martínez-Montiel; Gonzalo Jesús Gómez-Gómez; Ana Isabel Flores
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Authors:  Kristi Baker; Timo Rath; Magdalena B Flak; Janelle C Arthur; Zhangguo Chen; Jonathan N Glickman; Inti Zlobec; Eva Karamitopoulou; Matthew D Stachler; Robert D Odze; Wayne I Lencer; Christian Jobin; Richard S Blumberg
Journal:  Immunity       Date:  2013-11-27       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.